Role of immunosuppression in the evolution of Legionnaires' disease

Clinical Infectious Diseases

Volumn 26, Issue 1, 1998, Pages 14-19

  Pedro Botet, M L ^a   Sabria Leal, M ^b   Sopena, N ^b   Manterola, J M ^b   Morera, J ^b   Blavia, R ^b   Padilla, E ^b   Matas, L ^b   Gimeno, J M ^b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DAUNORUBICIN; DEFLAZACORT; DEXAMETHASONE; ERYTHROMYCIN; IFOSFAMIDE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; VINCRISTINE;

ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL;

EID: 0031887989     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516258     Document Type: Article

References (11)

1. Horwith MA. Toward an understanding of host and bacterial molecules mediating Legionella pneumophila pathogenesis. In: Barbaree JM, Breiman RF, Dufour AP, eds. Legionella: current status and emerging perspectives. Proceedings of the 4th International Symposium (Orlando). Washington, DC: American Society for Microbiology, 1992:55-62.
2. Kirby BD, Snyder KM, Meyer RD, Finegold SM. Legionnaires' disease: report of sixty-five nosocomially acquired cases and review of the literature. Medicine (Baltimore) 1980;59:188-205.
3. Meyer RD. Legionella infections: a review of five years of research. Rev Infect Dis 1983;5:258-78.
4. Carratalá J, Gudiol F, Pallarés R, et al. Risk factors for nosocomial Legionella pneumophila pneumonia. Am J Respir Crit Care Med 1994;149: 625-9.
5. England AC III, Fraser DW. Sporadic and epidemic nosocomial legionellosis in the United States: epidemiologic features. Am J Med 1981; 70:707-11.
6. Klaucke DN, Vogt RL, LaRue D, et al. Legionnaires' disease: the epidemiology of two outbreaks in Burlington, Vermont, 1980. Am J Epidemiol 1984;119:382-91.
7. Kugler JW, Armitage JO, Helms CM, et al. Nosocomial legionnaires' disease: occurrence in recipients of bone marrow transplants. Am J Med 1983;74:281-8.
8. Saravolatz LD, Burch KH, Fisher E, et al. The compromised host and legionnaires' disease. Ann Intern Med 1979;90:533-7.
9. Beaty HN, Miller AA, Broome CV, Goings S, Phillips CA. Legionnaires' disease in Vermont, May to October 1977. JAMA 1978;240:127-31.
10. Sheldon PA, Tight RR, Renner ED. Fatal legionnaires' disease coincident with initiation of immunosuppressive therapy. Arch Intern Med 1985; 145:1138-9.
11. Edelstein PH, Meyer RD. Legionnaires' disease: a review. Chest 1984; 85:114-20.